X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (464) 464
Book Review (82) 82
Publication (48) 48
Conference Proceeding (23) 23
Patent (14) 14
Book Chapter (12) 12
Book / eBook (6) 6
Dissertation (4) 4
Web Resource (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (272) 272
humans (264) 264
oncology (243) 243
female (133) 133
male (126) 126
aged (111) 111
middle aged (109) 109
adult (85) 85
neoplasms - drug therapy (70) 70
lung neoplasms - drug therapy (68) 68
antineoplastic combined chemotherapy protocols - therapeutic use (63) 63
chemotherapy (57) 57
treatment outcome (57) 57
aged, 80 and over (56) 56
cancer (56) 56
carcinoma, non-small-cell lung - drug therapy (54) 54
respiratory system (53) 53
research (50) 50
antineoplastic agents - therapeutic use (47) 47
animals (45) 45
dose-response relationship, drug (36) 36
lung neoplasms - pathology (36) 36
abridged index medicus (34) 34
antineoplastic combined chemotherapy protocols - adverse effects (34) 34
antineoplastic agents - pharmacology (32) 32
cell lung-cancer (32) 32
maximum tolerated dose (32) 32
article (31) 31
pharmacology & pharmacy (31) 31
clinical trials (30) 30
clinical trials as topic (30) 30
drug therapy (30) 30
lung cancer (28) 28
neoplasm staging (27) 27
solid tumors (27) 27
care and treatment (26) 26
antineoplastic agents - adverse effects (25) 25
apoptosis (24) 24
carcinoma (24) 24
cisplatin (24) 24
medicine & public health (24) 24
pemetrexed (24) 24
prognosis (24) 24
signal transduction - drug effects (24) 24
survival (24) 24
therapy (24) 24
lung neoplasms - mortality (23) 23
survival rate (23) 23
drug administration schedule (22) 22
guanine - analogs & derivatives (22) 22
lung neoplasms - therapy (22) 22
tumors (22) 22
antineoplastic agents - administration & dosage (21) 21
carcinoma, non-small-cell lung - pathology (21) 21
lung cancer, non-small cell (21) 21
pharmacology/toxicology (21) 21
dosage and administration (20) 20
gemcitabine (20) 20
neoplasms - pathology (20) 20
pharmacokinetics (20) 20
administration, oral (19) 19
cell line, tumor (18) 18
deoxycytidine - analogs & derivatives (18) 18
expression (18) 18
glutamates - administration & dosage (18) 18
guanine - administration & dosage (18) 18
lung neoplasms - genetics (18) 18
malaria (18) 18
phase-iii trial (18) 18
alkyl and aryl transferases - antagonists & inhibitors (17) 17
antitumor-activity (17) 17
cells (17) 17
follow-up studies (17) 17
hematology, oncology and palliative medicine (17) 17
mutations (17) 17
studies (17) 17
trial (17) 17
activation (16) 16
antineoplastic agents (16) 16
antineoplastic agents - pharmacokinetics (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (16) 16
antineoplastic combined chemotherapy protocols - pharmacokinetics (16) 16
area under curve (16) 16
carboplatin - administration & dosage (16) 16
deoxycytidine - administration & dosage (16) 16
hygiene (16) 16
neoplasms - metabolism (16) 16
phase-ii trial (16) 16
receptor, epidermal growth factor - antagonists & inhibitors (16) 16
analysis (15) 15
disease-free survival (15) 15
erlotinib (15) 15
farnesyltranstransferase (15) 15
lung neoplasms - diagnosis (15) 15
non-small cell lung cancer (15) 15
paclitaxel (15) 15
bevacizumab (14) 14
carboplatin (14) 14
carcinoma, non-small-cell lung - genetics (14) 14
carcinoma, non-small-cell lung - mortality (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Barber, Ryan M and Fullman, Nancy and Sorensen, Reed J D and Bollyky, Thomas and McKee, Martin and Nolte, Sandra and Nolte, Ellen and Abajobir, Amanuel Alemu and Abate, Kalkidan Hassen and Abbafati, Cristiana and Abbas, Kaja M and Abd-Allah, Foad and Abdulle, Abdishakur M and Abdurahman, Ahmed Abdulahi and Abera, Semaw Ferede and Abraham, Biju and Abreha, Girmatsion Fisseha and Adane, Kelemework and Adelekan, Ademola Lukman and Adetifa, Ifedayo Morayo O and Afshin, Ashkan and Agarwal, Sunilkumar and Agarwal, Sanjay Kumar and Agarwal, Arnav and Agrawal, Anurag and Kiadaliri, Aliasghar Ahmad and Ahmadi, Alireza and Ahmed, Kedir Yimam and Ahmed, Muktar Beshir and Akinyemi, Rufus Olusola and Akinyemiju, Tomi F and Akseer, Nadia and Al-Aly, Ziyad and Alam, Khurshid and Alam, Noore and Alam, Sayed Saidul and Alemu, Zewdie Aderaw and Alene, Kefyalew Addis and Alexander, Lily and Ali, Raghib and Ali, Syed Danish and Alizadeh-Navaei, Reza and Alkerwi, Ala'a and Alla, François and Allebeck, Peter and Allen, Christine and Al-Raddadi, Rajaa and Alsharif, Ubai and Altirkawi, Khalid A and Martin, Elena Alvarez and Alvis-Guzman, Nelson and Amare, Azmeraw T and Amini, Erfan and Ammar, Walid and Amo-Adjei, Joshu and Amoako, Yaw Ampem and Anderson, Benjamin O and Androudi, Sofia and Ansari, Hossein and Ansha, Mustafa Geleto and Antonio, Carl Abelardo T and Ärnlöv, Johan and Artaman, Al and Asayesh, Hamid and Assadi, Reza and Astatkie, Ayalew and Atey, Tesfay Mehari and Atique, Suleman and Atnafu, Niguse Tadele and Atre, Sachin R and Avila-Burgos, Leticia and Avokpaho, Euripide Frinel G Arthur and Quintanilla, Beatriz Paulina Ayala and Awasthi, Ashish and Ayele, Nebiyu Negussu and Azzopardi, Peter and Saleem, Huda Omer Ba and Bärnighausen, Till and Bacha, Umar and Badawi, Alaa and Banerjee, Amitava and Barac, Aleksandra and Barboza, Miguel A and Barker-Collo, Suzanne L and Barrero, Lope H and Basu, Sanjay and Baune, Bernhard T and Baye, Kaleab and Bayou, Yibeltal Tebekaw and Bazargan-Hejazi, Shahrzad and Bedi, Neeraj and Beghi, Ettore and Béjot, Yannick and Bello, Aminu K and Bennett, Derrick A and Bensenor, Isabela M and Berhane, Adugnaw and Bernabé, Eduardo and Bernal, Oscar Alberto and Beyene, Tariku Jibat and ... and GBD 2015 Healthcare Access Quality and GBD 2015 Healthcare Access and Quality Collaborators. Electronic address: cjlm@uw.edu and GBD 2015 Healthcare Access and Quality Collaborators and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Medicinsk vetenskap
The Lancet, ISSN 0140-6736, 07/2017, Volume 390, Issue 10091, pp. 231 - 266
Journal Article
2006, ISBN 0120885611, xv, 437 p., [20] p. of plates
This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition,... 
Development | Pharmacogenetics | Antineoplastic agents | Testing | Clinical & internal medicine | Research | Methodology
Book
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2018
Journal Article
Cancer Epidemiology Biomarkers & Prevention, ISSN 1055-9965, 02/2017, Volume 26, Issue 2 Supplement, pp. IA16 - IA16
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 2018
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2019, Volume 14, Issue 6, pp. 956 - 956
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 05/2019, Volume 14, Issue 5, pp. 757 - 757
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1610 - 1623
Journal Article
2003, Methods in Molecular Medicine, ISBN 0896039633, Volume 85, xv, 355
With many potential molecular targets of anticancer agents already identified and many more yet to be discovered, the great challenges are now to successfully... 
Chemotherapy | Research | Methodology | Antineoplastic agents | Cancer | Pharmacy
Book
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2018, Volume 13, Issue 3, pp. 290 - 290
Journal Article
Cancer and Metastasis Reviews, ISSN 0167-7659, 6/2015, Volume 34, Issue 2, pp. 169 - 171
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 09/2017, Volume 12, Issue 9, pp. 1334 - 1334
Journal Article
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 08/2018
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier... 
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2139 - 2146
Purpose To assess the tolerability, pharmacokinetics (PKs), and pharmacodynamics (PDs) of the mitogenactivated protein kinase kinase (MEK) 1/2 inhibitor... 
MEK INHIBITOR | POTENT | VIVO | ONCOLOGY | PATHWAY | GROWTH | COLON | TUMORS | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Melanoma - enzymology | Male | Antineoplastic Agents - administration & dosage | Extracellular Signal-Regulated MAP Kinases - metabolism | Protein Kinase Inhibitors - adverse effects | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Neoplasms - genetics | Antineoplastic Agents - adverse effects | DNA Mutational Analysis | Melanoma - genetics | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Benzimidazoles - adverse effects | Protein Kinase Inhibitors - pharmacokinetics | MAP Kinase Kinase 1 - antagonists & inhibitors | Leukocytes, Mononuclear - drug effects | Drug Administration Schedule | Administration, Oral | Benzimidazoles - pharmacokinetics | Neoplasms - enzymology | MAP Kinase Kinase 1 - metabolism | Proto-Oncogene Proteins - genetics | Treatment Outcome | MAP Kinase Kinase 2 - metabolism | Melanoma - pathology | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Ki-67 Antigen - analysis | MAP Kinase Kinase 2 - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Leukocytes, Mononuclear - enzymology | Aged | Cell Proliferation - drug effects | Mutation | Neoplasm Staging | Neoplasms - pathology | Index Medicus
Journal Article